Adicet Bio, Inc. (ACET) income statement
ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
$2.46−0.04 (-1.60%)
Close on Nov 19, 2026Market cap $23.03MP/E –Yield –
Adicet Bio, Inc. financial ratios
See a number that looks wrong?
Close on Nov 19, 2026Market cap $23.03MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns on capital | ||||||||||
| Return on equity | -67.6% | -65.7% | -61.7% | -23.4% | -30.0% | -148.3% | 59.9% | 30.8% | 250.7% | – |
| Return on assets | -56.6% | -54.8% | -53.0% | -20.8% | -25.2% | -31.2% | -29.4% | -11.3% | -61.2% | – |
| Return on tangible assets | -56.6% | -54.8% | -53.0% | -22.1% | -27.3% | -37.6% | -29.4% | -11.3% | -61.2% | – |
| Return on capital employed | -65.7% | -65.6% | -60.9% | -22.9% | -27.1% | -39.6% | -36.7% | -19.4% | -38.0% | – |
| NOPAT | -$96.47M | -$100.82M | -$120.11M | -$57.32M | -$48.53M | -$30.96M | -$24.80M | -$11.82M | -$14.92M | – |
| Cash flow quality | ||||||||||
| OCF / Net income | 0.82 | 0.79 | 0.66 | 0.64 | 0.82 | 1.13 | 0.99 | 1.96 | 0.33 | – |
| FCF / OCF | 101.8% | 101.2% | 104.8% | 137.5% | 125.6% | 102.4% | 103.8% | 104.8% | 100.4% | – |
| FCF / Net income | 0.83 | 0.80 | 0.69 | 0.88 | 1.03 | 1.16 | 1.03 | 2.05 | 0.33 | – |
| FCF / EBITDA | 83.8% | 77.2% | 67.3% | 88.0% | 107.0% | 112.1% | 96.0% | 138.7% | 58.4% | – |
| Unlevered free cash flow | -$96.96M | -$93.49M | -$98.16M | -$61.48M | -$63.96M | -$42.44M | -$28.95M | -$19.06M | -$11.03M | – |
| Levered free cash flow | -$96.98M | -$93.50M | -$98.18M | -$61.55M | -$64.10M | -$42.54M | -$28.95M | -$19.06M | -$11.03M | – |
| Efficiency | ||||||||||
| CapEx to OCF | -1.8% | -1.2% | -4.8% | -37.5% | -25.6% | -2.4% | -3.8% | -4.8% | -0.40% | – |
| CapEx to depreciation | 0.27 | 0.17 | 0.73 | 6.52 | 8.48 | 0.81 | 0.86 | 0.72 | 8.80 | – |
| Liquidity | ||||||||||
| Current ratio | 7.47 | 9.29 | 8.41 | 13.25 | 17.31 | 4.46 | 4.32 | 19.16 | 10.02 | – |
| Quick ratio | 7.47 | 9.29 | 8.41 | 13.25 | 17.31 | 4.46 | 4.32 | 19.16 | 10.02 | – |
| Cash ratio | 1.81 | 3.06 | 8.28 | 13.07 | 17.02 | 4.41 | 6.16 | 1.66 | 6.72 | – |
| Working capital | $139.40M | $160.74M | $142.99M | $241.33M | $266.12M | $77.86M | $49.32M | $103.82M | $49.65M | – |
| Net current asset value | $127.78M | $146.53M | $125.15M | $222.69M | $246.63M | $56.33M | $36.32M | $103.80M | $49.65M | – |
| Leverage | ||||||||||
| Assets to equity | 1.21 | 1.18 | 1.22 | 1.13 | 1.12 | 1.40 | -1.35 | -3.28 | -2.05 | – |
| Goodwill / Assets | – | – | 0.00% | 5.9% | 5.7% | 13.1% | – | – | – | – |
| Intangibles to total assets | – | – | 0.00% | 5.9% | 5.7% | 13.1% | – | – | – | – |
| Interest coverage | ||||||||||
| EBIT / Interest expense | -3,392.06 | -31,903.75 | -6,081.52 | -906.89 | -349.05 | -292.47 | – | – | – | – |
| EBITDA / Interest expense | -3,214.81 | -30,286.75 | -5,837.60 | -874.70 | -340.31 | -283.32 | – | – | – | – |
| (EBITDA − CapEx) / Interest expense | -3,263.08 | -30,566.25 | -6,016.16 | -1,084.48 | -414.44 | -290.71 | – | – | – | – |
| Per share | ||||||||||
| EPS (basic) | -16.95 | -21.33 | -52.96 | -27.20 | -32.00 | -80.16 | -210.40 | -76.48 | -2,245.33 | – |
| EPS (diluted) | -16.95 | -21.33 | -52.96 | -27.20 | -32.00 | -80.16 | -210.40 | -76.48 | -2,245.33 | – |
| Book value per share | 16.61 | 36.16 | 62.93 | 108.89 | 122.05 | 44.22 | -448.07 | -318.57 | -1,269.81 | – |
| Tangible book value per share | 16.61 | 36.16 | 62.93 | 101.64 | 114.22 | 36.13 | -448.07 | -318.57 | -1,269.81 | – |
| Cash per share | 4.06 | 11.51 | 59.06 | 95.97 | 111.81 | 39.92 | 679.17 | 90.06 | 1,741.07 | – |
| Operating cash flow per share | -9.94 | -17.90 | -34.65 | -16.67 | -20.56 | -16.73 | -206.96 | -172.80 | -517.62 | – |
| Free cash flow per share | -10.12 | -18.12 | -36.30 | -22.93 | -25.81 | -17.13 | -214.90 | -181.13 | -519.70 | – |
| CapEx per share | 0.18 | 0.22 | 1.65 | 6.25 | 5.25 | 0.40 | 7.94 | 8.33 | 2.07 | – |
| Valuation at period end | ||||||||||
| Market cap | $43.81M | $79.27M | $81.47M | $382.52M | $697.60M | $275.23M | $22.81M | $101.54M | – | – |
| Enterprise value | $14.71M | -$122.80M | -$101.78M | $99.84M | $505.38M | $167.11M | -$94.49M | -$13.86M | – | – |
| P/B | 0.3x | 0.4x | 0.5x | 1.3x | 2.3x | 2.5x | -0.4x | -3.0x | – | – |
| P/TBV | 0.3x | 0.4x | 0.5x | 1.4x | 2.5x | 3.1x | -0.4x | -3.0x | – | – |
| P/OCF | -0.5x | -0.9x | -0.9x | -8.5x | -13.7x | -6.6x | -0.8x | -5.6x | – | – |
| EV/EBITDA | – | 1.0x | 0.7x | – | – | – | 3.1x | 1.0x | – | – |
| EV/EBIT | – | 1.0x | 0.7x | – | – | – | 3.0x | 0.9x | – | – |
| EV/OCF | -0.2x | 1.3x | 1.1x | -2.2x | -9.9x | -4.0x | 3.4x | 0.8x | – | – |
| EV/FCF | – | 1.3x | 1.0x | – | – | – | 3.3x | 0.7x | – | – |
| Earnings yield | -266.6% | -147.8% | -175.1% | -18.2% | -8.9% | -13.3% | -123.4% | -9.2% | – | – |
| FCF yield | -221.4% | -117.9% | -120.5% | -16.1% | -9.2% | -15.5% | -126.9% | -18.8% | – | – |
| Shareholder yield | ||||||||||
| Dividend per share | – | – | – | – | – | 0.00 | 0.00 | 0.00 | – | – |
| Dividend yield | – | – | – | – | – | 0.00% | 0.00% | 0.00% | – | – |
| Per employee | ||||||||||
| Total employees | 102 | 152 | 143 | 132 | 86 | 81 | 18 | 21 | 7 | 7 |
| Operating profit per employee | -$1.20M | -$839.57K | -$1.06M | -$549.63K | -$714.34K | -$483.84K | -$1.74M | -$712.57K | -$2.70M | – |
| Net income per employee | -$1.15M | -$770.54K | -$997.61K | -$528.71K | -$720.92K | -$452.81K | -$1.56M | -$442.81K | -$4.83M | – |
| Free cash flow per employee | -$950.82K | -$615.11K | -$686.58K | -$466.27K | -$745.33K | -$525.21K | -$1.61M | -$907.43K | -$1.58M | – |
| Growth | ||||||||||
| EBIT 1Y growth | 4.3% | 16.1% | -109.6% | -18.1% | -56.8% | -24.9% | -109.8% | 20.7% | – | – |
| EBITDA 1Y growth | 4.5% | 17.0% | -108.6% | -16.8% | -57.8% | -25.9% | -119.4% | 27.2% | – | – |
| Net income 1Y growth | 0.27% | 17.9% | -104.4% | -12.6% | -69.0% | -30.4% | -202.6% | 72.5% | – | – |
| Diluted EPS 1Y growth | 20.5% | 59.7% | -94.7% | 15.0% | 60.1% | 61.9% | -175.1% | 96.6% | – | – |
| Operating cash flow 1Y growth | -3.1% | 1.4% | -109.4% | 12.3% | -22.9% | -49.0% | -53.4% | -65.5% | – | – |
| Free cash flow 1Y growth | -3.7% | 4.8% | -59.5% | 4.0% | -50.7% | -46.9% | -51.9% | -72.8% | – | – |
| CapEx 1Y growth | 55.5% | -75.0% | -73.4% | 28.6% | 1,217.8% | -7.5% | 22.1% | 1,890.9% | – | – |
| CapEx 3Y CAGR | -53.0% | -55.9% | 65.2% | 150.3% | 146.0% | 182.3% | – | – | – | – |
| CapEx 5Y CAGR | 11.9% | 0.88% | 38.5% | 228.3% | – | – | – | – | – | – |
| Total assets 1Y growth | -12.7% | 6.2% | -37.3% | -2.4% | 120.3% | 88.6% | -25.8% | 99.2% | – | – |
| Total assets 3Y CAGR | -16.5% | -13.4% | 10.5% | 59.4% | 45.5% | 40.7% | – | – | – | – |
| Total assets 5Y CAGR | 4.6% | 22.0% | 13.5% | 43.1% | – | – | – | – | – | – |
| Total equity 1Y growth | -14.7% | 9.7% | -41.8% | -3.6% | 176.0% | 281.9% | -80.1% | -24.4% | – | – |
| Total equity 3Y CAGR | -18.3% | -14.9% | 15.7% | – | – | – | – | – | – | – |
| Total equity 5Y CAGR | 7.7% | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.